Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke
- PMID: 22223855
- DOI: 10.1093/infdis/jir788
Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke
Abstract
Concerns have arisen about possible effects of protease inhibitors (PIs) on cardiac conductivity. We found no significant association between current or recent PI exposure and sudden death or nonhemorrhagic stroke (adjusted rate ratio, 1.22; 95% confidence interval, .95-1.57), whereas cumulative exposure to PIs was associated with an increased risk (adjusted rate ratio, 1.06 per year of exposure; 95% confidence interval, 1.01-1.11).
Comment in
-
PR Interval and sudden cardiac death in patients with HIV infection.J Infect Dis. 2013 Jan 1;207(1):199-200. doi: 10.1093/infdis/jis655. Epub 2012 Nov 27. J Infect Dis. 2013. PMID: 23186784 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous

